title: Use of whole-body FDG PET-CT to aid in the diagnosis of occult sarcoidosis.
abstract: OBJECTIVE
  To report a case where combined whole-body Fluorine-18 fluorodeoxyglucose (FDG) PET-CT scanning was used to aid in the diagnosis of a patient with occult sarcoidosis.
  
  
  METHODS
  Case report.
  
  
  METHODS
  FDG PET-CT scanning was performed in a patient who presented with persistent bilateral panuveitis after cataract surgery and had undergone an extensive negative workup.
  
  
  RESULTS
  FDG PET-CT scanning demonstrated extensive mediastinal adenopathy. Biopsy showed a non-caseating granuloma with associated giant cell formation consistent with a diagnosis of sarcoidosis.
  
  
  CONCLUSIONS
  FDG PET-CT scanning generates tomographic scans with excellent sensitivity, spatial resolution, and anatomical landmark identification and may be useful in the workup of idiopathic uveitis.
authors: UMDNJ - New Jersey Medical School, The Institute of Ophthalmology and Visual Science, Newark, New Jersey, USA.
authors: Bradford L
authors: BL
authors: Tannen
authors: Nasrin V
authors: NV
authors: Ghesani
authors: Larry
authors: L
authors: Frohman
authors: Joel D
authors: JD
authors: Eichler
authors: Pierre D
authors: PD
authors: Maldjian
authors: David S
authors: DS
authors: Chu
mesh_terms: D000368:Aged; D002387:Cataract Extraction; D005260:Female; D019788:Fluorodeoxyglucose F18; D006801:Humans; D049268:Positron-Emission Tomography; D011183:Postoperative Complications / Q000209:etiology; D019275:Radiopharmaceuticals; D012507:Sarcoidosis / Q000150:complications / Q000175:diagnosis*; D014057:Tomography, X-Ray Computed; D014605:Uveitis / Q000209:etiology
chemical_list: D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18